HRAS and lung adenocarcinoma: Interestingly, it has also been confirmed that Chr-A induces the accumulation of ROS, causing DNA damage in KARS-mutated lung adenocarcinoma [27] and Staphylococcus aureus [91], suggesting that Chr-A exerts various pharmacological activities through modulating ROS levels.